Clinical trial
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
NCT00033631 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00033631 |
|---|---|
| Title | Radiation Therapy in Treating Patients With Stage II Prostate Cancer |
| Official title | A Phase III Randomized Study Of High Dose 3D-CRT/IMRT Versus Standard Dose 3D-CRT/IMRT In Patients Treated For Localized Prostate Cancer |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Radiation |
| Interventions | 70.2 Gy 3D-CRT/IMRT, 79.2 Gy 3D-CRT/IMRT |
| Enrollment | 1,534 |
| Start date | Mar 1, 2002 |
| Primary completion | Apr 1, 2014 |
| Completion | Dec 22, 2022 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 18, 2023 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: